Understanding and learning from the success of prophylactic human papillomavirus vaccines
出版年份 2012 全文链接
标题
Understanding and learning from the success of prophylactic human papillomavirus vaccines
作者
关键词
-
出版物
NATURE REVIEWS MICROBIOLOGY
Volume 10, Issue 10, Pages 681-692
出版商
Springer Nature
发表日期
2012-09-10
DOI
10.1038/nrmicro2872
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- The Perpetual Challenge of Infectious Diseases
- (2012) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy Results of a Trial of a Herpes Simplex Vaccine
- (2012) Robert B. Belshe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
- (2012) Cecilia M. Roteli-Martins et al. Human Vaccines & Immunotherapeutics
- Developments in virus-like particle-based vaccines for infectious diseases and cancer
- (2011) Luigi Buonaguro et al. Expert Review of Vaccines
- Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
- (2011) Morgane Bomsel et al. IMMUNITY
- HSV-2: in pursuit of a vaccine
- (2011) Christine Johnston et al. JOURNAL OF CLINICAL INVESTIGATION
- Genital Transmission of Human Papillomavirus in Recently Formed Heterosexual Couples
- (2011) A. N. Burchell et al. JOURNAL OF INFECTIOUS DISEASES
- Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease
- (2011) Anil K. Chaturvedi et al. JOURNAL OF INFECTIOUS DISEASES
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
- (2011) Aimée R. Kreimer et al. JNCI-Journal of the National Cancer Institute
- A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection
- (2011) S. Longet et al. JOURNAL OF VIROLOGY
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Primary human epithelial cell culture system for studying interactions between female upper genital tract and sexually transmitted viruses, HSV-2 and HIV-1
- (2011) Charu Kaushic et al. METHODS
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- (2011) Joel M. Palefsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection
- (2011) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
- (2011) Troy J. Kemp et al. VACCINE
- Herpes simplex virus infects most cell types in vitro: clues to its success
- (2011) Ghadah A Karasneh et al. Virology Journal
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- HIV vaccine development at the turn of the 21st century
- (2011) Marc P. Girard et al. Current Opinion in HIV and AIDS
- The Role of Antibodies in HIV Vaccines
- (2010) John R. Mascola et al. Annual Review of Immunology
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
- (2010) Patricia M. Day et al. Cell Host & Microbe
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
- (2010) Ian J. Amanna et al. IMMUNOLOGICAL REVIEWS
- Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design
- (2010) Jiri Mestecky et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
- (2010) Basil Donovan et al. LANCET INFECTIOUS DISEASES
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
- (2010) Hans-Ulrich Bernard et al. VIROLOGY
- Strategies for eliciting HIV-1 inhibitory antibodies
- (2010) Georgia D Tomaras et al. Current Opinion in HIV and AIDS
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
- (2009) Suzanne M. Garland et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
- (2009) S. K. Lai et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding
- (2009) R. C. Kines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine
- (2009) Sita Awasthi et al. VACCINE
- Oncogenic activities of human papillomaviruses
- (2009) Margaret E. McLaughlin-Drubin et al. VIRUS RESEARCH
- HIV infection of the genital mucosa in women
- (2009) Florian Hladik et al. Current HIV/AIDS Reports
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- Immunobiology of HPV and HPV vaccines
- (2008) Margaret Stanley GYNECOLOGIC ONCOLOGY
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- The Human Immunodeficiency Virus Type 1 Envelope Spike of Primary Viruses Can Suppress Antibody Access to Variable Regions
- (2008) R. Pantophlet et al. JOURNAL OF VIROLOGY
- Blocking Antibody Access to Neutralizing Domains on Glycoproteins Involved in Entry as a Novel Mechanism of Immune Evasion by Herpes Simplex Virus Type 1 Glycoproteins C and E
- (2008) L. M. Hook et al. JOURNAL OF VIROLOGY
- Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis
- (2008) Kimberly A Powers et al. LANCET INFECTIOUS DISEASES
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
- (2008) Elmar A. Joura et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now